Patents remain an important way for research-intensive universities to exploit their work, but the commercialisation scene is changing. Direct licensing to large companies appears to be in decline, with universities increasingly expected to develop technologies to higher levels of maturity and lower the risk, and new actors stepping in to support university ecosystems.
Centre for Drug Design Secures €70 5M for Fourth Fund miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
The new capital is provided by KU Leuven Research & Development (LRD) and the European Investment Fund (EIF), whose contribution is supported under the European Commission’s InvestEU initiative, as well as by the Gemma Frisius Fund (GFF). It will be used to transform groundbreaking biomedical discoveries from both biotech companies and especially academic research groups at KU Leuven and other universities, into new medicines that improve people’s lives worldwide.